OpenVSafe by OpenVAERS
Search V-safe

EJF-21002-61605

3 vaccinations 2 coded responses 10 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
323 / FL
Registered
2021-12-21
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-12
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-02
    Dose 2 — Pfizer-BioNTech
  3. 2021-12-20
    Dose 3 — Pfizer-BioNTech
  4. 2021-12-21
    Registered in v-safe
  5. 2021-12-21
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Fatigue or tiredness, Diarrhea
    Adult check-in
  6. 2021-12-22
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-12-23
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  8. 2021-12-24
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  9. 2021-12-27
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  10. 2022-01-03
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  11. 2022-01-12
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  12. 2022-01-24
    Survey response — day 35, dose 3
    MedDRA: Headache, Oropharyngeal pain, Respiratory tract congestion, Vomiting — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Possible Covid-19. Headache, sore throat, congestion, and vomiting.
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-01-31
    Survey response — day 42, dose 3
    MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Had Covid.
    MedDRA releases: 2024-11 · check-in free text available
  14. 2022-12-20
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-12Pfizer-BioNTech No
22021-04-02Pfizer-BioNTech No
32021-12-20Pfizer-BioNTech No

Free text

Release 11 — day 35, dose 3

2022-01-24

Symptoms: Possible Covid-19. Headache, sore throat, congestion, and vomiting.

Release 11 — day 42, dose 3

2022-01-31

Symptoms: Had Covid.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCOVID-19 · · ✓
SDHeadache · · ✓
SDOropharyngeal pain · · ✓
SDRespiratory tract congestion · · ✓
SDVomiting · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release